Completed NA INTERVENTIONAL 2-arm NCT03524534

The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study (THRIVE)

Sponsor: Kaiser Permanente

Interventions In-Person Primary Care Clinical Follow-Up Visit Telephone Call

Updated 8 times since 2018 Last updated: Jun 9, 2023 Started: Jan 31, 2017 Primary completion: Sep 30, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03524534, this NA trial focuses on Heart Failure and remains completed. Sponsored by Kaiser Permanente, it has been updated 8 times since 2017, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2023 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Jul 2023 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

Feb 2019 — Sep 2020 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Dec 2018 — Feb 2019 [monthly]

Active Not Recruiting NA
Jun 2018 — Dec 2018 [monthly]

Active Not Recruiting NA

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kaiser Permanente
The Permanente Medical Group

Data source: Kaiser Permanente

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.